5-MAPB also known as 5-(2-methylaminopropyl) benzofuran, is a synthetic entactogen of the benzofuran class. 5-MAPB is known for its stimulating, euphoric and entactogenic outcomes. 5-MAPB
includes MDA-inspired substances as 5-APB, 6-APB and 5-EAPB, among others. 5-MAPB has been rising in popularity as a research chemical since 2010. 5-MAPB is structurally similar to
3,4-Methyl​enedioxy​methamphetamine, also known as Molly or MDMA, first developed in 1912 by Merck. In theory, it acts primarily by increasing the neurotransmitters serotonin, dopamine, and
noradrenaline activity and belongs to the substituted amphetamine classes